2023-07-19T00:51:08Z
ENA-FIRST-PUBLIC
2023-07-19T00:51:07Z
ENA-LAST-UPDATE
GSM6732490
External Id
SAMN31739613
External Id
2023-07-19T00:51:08Z
INSDC first public
2023-07-19T00:51:07Z
INSDC last update
public
INSDC status
SRS15765450
SRA accession
GSM6732490
Submitter Id
NCBI
broker name
Expanded TIL
cell line
CD4+
cell type
H3 pan-acetyl
chip antibody
missing
collection_date
human
common name
1
dataset
male
gender
missing
geo_loc_name
88.05%
infusion percent_cd4
6.18%
infusion percent_cd8
5.20E+10
number til_infused
Homo sapiens
organism
102
overall survival_months
0
pfs censor_at_12_months
102
pfs months
CR
response
Homo sapiens
scientific_name
TIL ACT Product
source_name
0
survival censor
TIL ACT Product
tissue
Patient 2 CD4+ [Pt02_CD4]
title
TIL ACT
treatment
15781
trial